Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Mitchell J., Camacho N., Shea P., Stopsack KH., Joseph V., Burren O., Dhindsa R., Nag A., Berchuck JE., O'Neill A., Abbasi A., Zoghbi AW., Alegre-Díaz J., Kuri-Morales P., Berumen J., Tapia-Conyer R., Emberson J., Torres JM., Collins R., Wang Q., Goldstein D., Matakidou A., Haefliger C., Anderson-Dring L., March R., Jobanputra V., Dougherty B., Carss K., Petrovski S., Kantoff PW., Offit K., Mucci LA., Pomerantz M., Fabre MA.

DOI

10.1101/2024.05.10.24307164

Type

Preprint

Publication Date

2024-05-10T00:00:00+00:00

Permalink More information Close